Catiuscia Molz de Freitas Selected Research

Catiuscia Molz de Freitas Research Topics

5	Tardive Dyskinesia 01/2018 - 10/2014
4	Dyskinesias (Dyskinesia) 12/2020 - 10/2014
2	Schizophrenia (Dementia Praecox) 11/2017 - 01/2016
1	Brain Diseases (Brain Disorder) 04/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2019
1	Motor Disorders 11/2017
1	Body Weight (Weight, Body) 11/2017
1	Parkinson Disease (Parkinson's Disease) 02/2016
1	Nervous System Diseases (Neurological Disorders) 02/2016
1	Movement Disorders (Movement Disorder) 10/2014

3	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 10/2014
2	Reserpine (Serpasil)FDA Link 12/2020 - 02/2016
2	Monoamine Oxidase (MAO)IBA 04/2019 - 11/2017
2	Fluphenazine (Prolixin)FDA LinkGeneric 11/2017 - 05/2016
1	Catechin (Z 7300)IBA 12/2020
1	IsoflavonesIBA 04/2019
1	AntioxidantsIBA 04/2019
1	ResveratrolIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 05/2016
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 02/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2016
1	Haloperidol (Haldol)FDA LinkGeneric 10/2014
1	EndocannabinoidsIBA 10/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2014
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2014
1	CannabinoidsIBA 10/2014